Related Experiment Videos
Constant kinetics and constant concentration-effect relationship during long-term beta-blockade with pindolol
Clinical Pharmacology and Therapeutics
|June 1, 1983
Summary
Long-term use of the beta-blocker pindolol did not reduce its effectiveness. This study found that pindolol maintains stable pharmacokinetics and beta-blockade effects over four weeks, refuting tachyphylaxis.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
Background:
- Long-term beta-blockade may alter beta-receptor density, potentially reducing drug efficacy.
- Understanding the long-term effects of beta-blockers is crucial for clinical practice.
Purpose of the Study:
- To investigate the hypothesis that prolonged beta-blockade with pindolol leads to reduced effectiveness.
- To assess the stability of pindolol's pharmacokinetic and pharmacodynamic profile over a 4-week period.
Main Methods:
- Nine healthy subjects received 15 mg of pindolol daily for 4 weeks.
- Measurements included plasma concentrations, isoproterenol dose-response curves, and plasma levels of renin, epinephrine, and norepinephrine.
- Pharmacokinetic parameters (clearance, volume of distribution) and concentration-effect relationships were analyzed.
Main Results:
- Pindolol demonstrated stable pharmacokinetic parameters (Cltot, Vdss) throughout the study.
- The concentration-effect relationship remained consistent, indicating no diminished beta-blockade.
- While basal renin activity was slightly reduced and stimulated renin blunted, the initial acute effects on renin diminished over time.
Conclusions:
- Pindolol exhibits a stable kinetic profile and consistent beta-blockade over 4 weeks of daily administration.
- The study concludes that pindolol does not induce tachyphylaxis (a decrease in drug responsiveness) with long-term use.